SmartGene Overview
- Year Founded
-
1998
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
SmartGene General Information
Description
Developer of bio-informatics application designed for the analysis, interpretation and data management of genetic sequences. The company's platform uses cloud-based modules for multiple applications, including human immunodeficiency virus (HIV) genotyping and resistance, influenza analysis, bacterial and fungal identification, microbiome analysis, strain-typing and molecular epidemiology of viruses and bacteria as well as provides clinical research designed for routine workflows, enabling physicians to follow analytical procedures efficiently and understand genetic variations, mutations and their implications for diseases.
Contact Information
Website
www.smartgene.comCorporate Office
- EPFL Innovation Park
- PSE-C
- 1015 Lausanne
- Switzerland
Corporate Office
- EPFL Innovation Park
- PSE-C
- 1015 Lausanne
- Switzerland
SmartGene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
SmartGene Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SmartGene Patents
SmartGene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2705216-C | Method and computer system for assessing classification annotations assigned to dna sequences | Active | 29-Nov-2007 | 000000000 | |
| EP-2215578-A1 | Method and computer system for assessing classification annotations assigned to dna sequences | Active | 29-Nov-2007 | 000000000 | |
| US-20180046756-A1 | Method and computer system for assessing classification annotations assigned to dna sequences | Inactive | 29-Nov-2007 | ||
| US-20210193269-A1 | Method for assessing classification annotations assigned to dna sequences of organisms | Inactive | 29-Nov-2007 | 000000000 | |
| CA-2705216-A1 | Method and computer system for assessing classification annotations assigned to dna sequences | Active | 29-Nov-2007 | G16B50/10 |
SmartGene Executive Team (2)
| Name | Title | Board Seat |
|---|---|---|
| Stefan Emler | Founder, Chief Executive Officer & Board Member | |
| Matthijs Verzijl | Chief Information Security Officer & System Administrator |
SmartGene Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Mechthild Ackermann | Self | Board Member | 000 0000 |
| Stefan Emler | SmartGene | Founder, Chief Executive Officer & Board Member | 000 0000 |
SmartGene Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
SmartGene Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EPFL Innovation Park | Accelerator/Incubator | 000 0000 | 000000 0 |
SmartGene FAQs
-
When was SmartGene founded?
SmartGene was founded in 1998.
-
Who is the founder of SmartGene?
Stefan Emler is the founder of SmartGene.
-
Who is the CEO of SmartGene?
Stefan Emler is the CEO of SmartGene.
-
Where is SmartGene headquartered?
SmartGene is headquartered in Lausanne, Switzerland.
-
What is the size of SmartGene?
SmartGene has 11 total employees.
-
What industry is SmartGene in?
SmartGene’s primary industry is Other Healthcare Technology Systems.
-
Is SmartGene a private or public company?
SmartGene is a Private company.
-
What is SmartGene’s current revenue?
The current revenue for SmartGene is 00000.
-
Who are SmartGene’s investors?
EPFL Innovation Park has invested in SmartGene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
